| Clinical data | |
|---|---|
| Trade names | Celospor, Celtol, Cristacef |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Intravenous,intramuscular, intramammary |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | 23 to 38% |
| Eliminationhalf-life | 1.2 hours |
| Excretion | Renal (72%) |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.030.449 |
| Chemical and physical data | |
| Formula | C13H13N3O6S |
| Molar mass | 339.32 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Cefacetrile (INN, also spelled cephacetrile) is abroad-spectrum first generationcephalosporinantibiotic effective ingram-positive andgram-negative bacterial infections. It is abacteriostatic antibiotic.[1][2] Cefacetrile is marketed under the trade namesCelospor,Celtol, andCristacef,[3] and asVetimast for the treatment ofmammary infections in lactating cows.[2]

It was made by reacting7-ACA (7-aminocephalosporanic acid) with cyanoacetyl chloride in the presence oftributylamine.[citation needed]
This systemicantibiotic-related article is astub. You can help Wikipedia byexpanding it. |